关注
Abraham H. Abouzeid
Abraham H. Abouzeid
在 nist.gov 的电子邮件经过验证
标题
引用次数
引用次数
年份
Nanopreparations to overcome multidrug resistance in cancer
NR Patel, BS Pattni, AH Abouzeid, VP Torchilin
Advanced drug delivery reviews 65 (13-14), 1748-1762, 2013
3582013
The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors
C Sarisozen, AH Abouzeid, VP Torchilin
European Journal of Pharmaceutics and Biopharmaceutics 88 (2), 539-550, 2014
1662014
Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer
AH Abouzeid, NR Patel, VP Torchilin
International journal of pharmaceutics 464 (1-2), 178-184, 2014
1372014
Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells
AH Abouzeid, NR Patel, C Sarisozen, VP Torchilin
Pharmaceutical research 31, 1938-1945, 2014
672014
Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin
AH Abouzeid, NR Patel, IM Rachman, S Senn, VP Torchilin
Journal of drug targeting 21 (10), 994-1000, 2013
652013
Divergent activities of osteogenic BMP2, and tenogenic BMP12 and BMP13 independent of receptor binding affinities
SP Berasi, U Varadarajan, J Archambault, M Cain, TA Souza, A Abouzeid, ...
Growth factors 29 (4), 128-139, 2011
612011
Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems
NR Patel, B Aryasomayajula, AH Abouzeid, VP Torchilin
Therapeutic delivery 6 (4), 509-520, 2015
492015
The role of cell cycle in the efficiency and activity of cancer nanomedicines
AH Abouzeid, VP Torchilin
Expert Opinion on Drug Delivery 10 (6), 775-786, 2013
272013
Intra-and trans-cellular delivery of enzymes by direct conjugation with non-multivalent anti-ICAM molecules
R Ghaffarian, N Roki, A Abouzeid, W Vreeland, S Muro
Journal of Controlled Release 238, 221-230, 2016
102016
In silico, in vitro and in vivo safety evaluation of Limosilactobacillus reuteri strains ATCC PTA-126787 & ATCC PTA-126788 for potential probiotic applications
D Gangaiah, SP Mane, NR Tawari, N Lakshmanan, V Ryan, A Volland, ...
Plos one 17 (1), e0262663, 2022
72022
Surface-modified micellar formulations of curcumin co-loaded with chemotherapeutic agents for enhanced anti-cancer effect
AH Abouzeid
Northeastern University, 2013
32013
ICAM-1 targeting by direct conjugation enhances gastrointestinal transcytosis and encapsulation enables gastric protection and controlled released for oral enzyme delivery
R Ghaffarian, H Oh, A Abouzeidc, W Vreelandc, S Raghavan, S Muro
Molecular Genetics and Metabolism 2 (117), S49, 2016
12016
Endocytosis of monomeric ICAM-1 targeting moieties provides intracellular transport of active enzyme conjugates
WN Vreeland, AH Abouzeid, S Muro, R Ghaffarian
Wyatt N. Vreeland, Abraham H. Abouzeid, Silvia Muro, Rasa Ghaffarian 238 …, 2016
2016
Nanotechnology-based treatment for chemotherapy-resistant breast cancer
AH Abouzeid, NR Patel, IM Rachman, S Senn, VP Torchilin
Biosensing and Nanomedicine VII 9166, 31-38, 2014
2014
Polyethylene Glycol–Phosphatidylethanolamine (PEG–PE)/Vitamin E Based Micelles for the Co-Delivery of Paclitaxel and Curcumin to Overcome Multi-Drug Resistance in Cancer
A Abouzeid, V Torchilin
3D Cancer Cell Spheroids as a Model For Investigating Co-Delivery of Paclitaxel and Curcumin by Targeted Mixed Micelles
C Sarisozen, AH Abouzeid, NR Patel, F Perche, VP Torchilin
系统目前无法执行此操作,请稍后再试。
文章 1–16